CSL Behring | Opening of a new manufacturing facility in Bern (Switzerland)
Share this article
To meet the high demands for immunoglobulin products, CSL Behring is expanding its manufacturing capacities in Bern
The new state-of-the-art manufacturing facility in Bern (Wankdorf) is home to the production of immunoglobulins (Ig), which allow people worldwide with serious and rare diseases to live life to the fullest.
A huge investment project in Bern
To meet the high demands for our immunoglobulin products, a new building is erected that will accommodate two additional manufacturing lines for immunoglobulin products. It is a multi-storey building with two manufacturing lines, and it is connected to the Logistics- and Service-Center (GBZ). CSL Behring invests 250 mio. Francs in the building project and creates approximately 50 new jobs in the city of Bern. This production expansion allows 90’000 additional patients to live life to the fullest – thanks to our life-saving immunoglobulins.
Fact & Figures
Production capacity: 2 manufacturing lines
Size of land: 5,030 m2
Building volume: 108,045 m3
Volume of concrete: 13,500 m3
Build-in concrete: 11,610 m2
More details here